WUXI BIOLOGICS (CAYMAN) INC earnings per share and revenue

2269 earnings per share for the last semiannual are 0.38 HKD whereas the estimation was 0.44 HKD which accounts for -14.63% surprise. Company revenue for the same period amounts to 9.21 B HKD despite the estimated figure of 8.98 B HKD. Estimated earnings per share for the next semiannual are 0.43 HKD, and revenue is expected to reach 10.26 B HKD. Also watch annual changes over time to get a bigger picture of 2269 earnings per share and revenue dynamics.